Wealth Enhancement Trust Services’s Anika Therapeutics ANIK Stock Holding History

Wealth Enhancement Trust Services’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$234	Buy	+16	New	+$237	﹤0.01%	1342

Other funds holding ANIK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

HIM

Hillsdale Investment Management Toronto, Ontario, Canada $4.39B AUM 72.96% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Wealth Enhancement Trust Services's ANIK Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Anika Therapeutics (ANIK) in Q2 2026: 16 shares worth $234. The stake represents ﹤0.01% of the portfolio and ranks #1342 among its holdings.

68 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

Wealth Enhancement Trust Services held 16 shares of Anika Therapeutics worth $234 as of Q2 2026.
Anika Therapeutics was a new Wealth Enhancement Trust Services position in Q2 2026.
Anika Therapeutics made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1342 holding.
68 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.